Literature DB >> 19059107

Changes in regulatory microRNA expression in myocardium of heart failure patients on left ventricular assist device support.

Marguérite E I Schipper1, Joyce van Kuik, Nicholas de Jonge, Hub F J Dullens, Roel A de Weger.   

Abstract

BACKGROUND: Left ventricular assist device support in heart failure patients leads to changes in mRNA and protein expression in the myocardium.
METHODS: MicroRNA's are important regulators of various cellular processes, so changes in their expression were tested by Q-PCR methods.
RESULTS: LVAD support (independently of the duration) leads to a decrease of the expression of miR-1, miR-133a and miR-133b in DCM patients but to an increase in expression in IHD patients. The expression of miR's pre- and post-LVAD in heart failure patients was low compared to the level of miR's in control myocardial tissue.
CONCLUSIONS: Alterations in miRs expression might also be important during repair processes in IHD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059107     DOI: 10.1016/j.healun.2008.09.005

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  25 in total

Review 1.  microRNAs in heart disease: putative novel therapeutic targets?

Authors:  Gianluigi Condorelli; Michael V G Latronico; Gerald W Dorn
Journal:  Eur Heart J       Date:  2010-01-29       Impact factor: 29.983

2.  Feedback mechanisms for cardiac-specific microRNAs and cAMP signaling in electrical remodeling.

Authors:  Richard Myers; Valeriy Timofeyev; Ning Li; Catherine Kim; Hannah A Ledford; Padmini Sirish; Victor Lau; Yinuo Zhang; Kiran Fayyaz; Anil Singapuri; Javier E Lopez; Anne A Knowlton; Xiao-Dong Zhang; Nipavan Chiamvimonvat
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-05-20

3.  MicroRNAs and heart failure diagnosis: MiR-acle or MiR-age?

Authors:  David W Markham; Joseph A Hill
Journal:  Circ Res       Date:  2010-04-02       Impact factor: 17.367

Review 4.  Left ventricular assist device-induced reverse remodeling: it's not just about myocardial recovery.

Authors:  Karolina K Marinescu; Nir Uriel; Douglas L Mann; Daniel Burkhoff
Journal:  Expert Rev Med Devices       Date:  2016-12-22       Impact factor: 3.166

5.  Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling.

Authors:  Tomoko S Kato; Aalap Chokshi; Parvati Singh; Tuba Khawaja; Faisal Cheema; Hirokazu Akashi; Khurram Shahzad; Shinichi Iwata; Shunichi Homma; Hiroo Takayama; Yoshifumi Naka; Ulrich Jorde; Maryjane Farr; Donna M Mancini; P Christian Schulze
Journal:  Circ Heart Fail       Date:  2011-07-15       Impact factor: 8.790

6.  Myocardial microRNAs associated with reverse remodeling in human heart failure.

Authors:  Carmen C Sucharov; David P Kao; J David Port; Anis Karimpour-Fard; Robert A Quaife; Wayne Minobe; Karin Nunley; Brian D Lowes; Edward M Gilbert; Michael R Bristow
Journal:  JCI Insight       Date:  2017-01-26

Review 7.  MicroRNAs in cardiovascular diseases: biology and potential clinical applications.

Authors:  Reena V Kartha; Subbaya Subramanian
Journal:  J Cardiovasc Transl Res       Date:  2010-02-25       Impact factor: 4.132

Review 8.  Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects.

Authors:  Amrut V Ambardekar; Peter M Buttrick
Journal:  Circ Heart Fail       Date:  2011-03       Impact factor: 8.790

9.  microRNA-133a attenuates cardiomyocyte hypertrophy by targeting PKCδ and Gq.

Authors:  Se-Yeon Lee; Chang Youn Lee; Onju Ham; Jae Yoon Moon; Jiyun Lee; Hyang-Hee Seo; Sunhye Shin; Sang Woo Kim; Seahyoung Lee; Soyeon Lim; Ki-Chul Hwang
Journal:  Mol Cell Biochem       Date:  2017-08-09       Impact factor: 3.396

10.  MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts.

Authors:  Scot J Matkovich; Wei Wang; Yizheng Tu; William H Eschenbacher; Lisa E Dorn; Gianluigi Condorelli; Abhinav Diwan; Jeanne M Nerbonne; Gerald W Dorn
Journal:  Circ Res       Date:  2009-11-05       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.